Cognition Therapeutics, Inc.
CGTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $28 | $55 | $61 | $140 |
| - Cash | $25 | $30 | $42 | $55 |
| + Debt | $1 | $1 | $1 | $0 |
| Enterprise Value | $4 | $27 | $21 | $86 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$34 | -$26 | -$21 | -$11 |
| % Margin | – | – | – | – |
| Net Income | -$34 | -$26 | $1 | -$12 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.85 | -0.86 | -0.74 | -0.73 |
| % Growth | 1.2% | -16.2% | -1.4% | – |
| Operating Cash Flow | -$28 | -$16 | -$19 | -$4 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$28 | -$16 | -$19 | -$4 |